Company intelligence / Profile preview

Rexar Pharmacal

Valley Stream, New York, United States

Ownership: Private
Development stage: Other

Overview

Rexar Pharmacal was the original manufacturer of Obetrol, a multi-salt amphetamine medication originally indicated for weight loss. The company and its product assets were acquired in 1994 by Richwood Pharmaceuticals, which reformulated and rebranded Obetrol as Adderall for the treatment of ADHD.

Therapeutic areas: NeurologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Rexar Pharmacal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rexar Pharmacal.

Explore the full profile